Brian Shin currently serves as Managing Partner at VitalStage Ventures and has an extensive investment background, including roles as an investor at Groq, Deepnight (YC W24), ego (YC W24), and Octolane AI (YC W24). Brian Shin holds an MBA from the MIT Sloan School of Management, earned between 2004 and 2006, and is pursuing a Master of Science degree in the Biomedical Enterprise Program at Harvard-MIT Health Sciences and Technology.